Mitoxantrone versus doxorubicin in advanced breast cancer: A randomized cross-over trial
- 31 December 1983
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 10, 41-46
- https://doi.org/10.1016/0305-7372(83)90021-x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Assessment of response of bone metastases to systemic treatment in patients with breast cancerCancer, 1983
- 5-Fluorouracil + oncovin + adriamycin + mitomycin c (FOAM): Ań Effective Program for Breast Cancer, Even for Disease Refractory to Previous Chemotherapy A Northern California Oncology Group (NCOG) StudyCancer, 1983
- Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicityCancer, 1983
- FAILURE OF CHEMOTHERAPY TO PROLONG SURVIVAL IN A GROUP OF PATIENTS WITH METASTATIC BREAST CANCERThe Lancet, 1980
- Cancer of the BreastNew England Journal of Medicine, 1980
- Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysisJAMA, 1979
- Adriamycin in combination for the treatment of breast cancer.A southwest oncology group studyCancer, 1978